ASA 1-2 |
29 (80.6%) |
13 (46.4%) |
0.004 |
ASA 3 |
7 (19.4%) |
15 (53.6%) |
|
Comorbidity
Present
Absent
|
17 (47.2%)
17 /47.2%)
|
7 (25%)
21 (75%)
|
0.025
|
Preoperative Hospitalization period, day
Comorbidity present
Comorbidity absent
|
3.9±2.6
6.1±4.0
|
5.9±2.5
9.8±4.2
|
0.047
0.008
|
Surgery Duration (min) (mean±SD)
|
125.4±29.5 |
148.9±39.9 |
0.018 |
Hematocrit (n, %)
<30
>30
|
16 (44,4%)
20 (55,6%)
|
21 (75%)
7 (25%)
|
0.014
|
Atropine (n, %)
Administered
Not administered
|
34 (94.4%)
2 (5.6%)
|
26 (92.9%)
2 (7.1%)
|
>0.999
|
Ephedrine (n, %)
Administered
Not administered
|
33 (91.7%)
3 (8.3%)
|
15 (53.6%)
13 (46.4%)
|
<0.001
|
Midazolam (n, %)
Administered
Not administered
|
19 (52.8%)
17 (47.2%)
|
19 (67.9%)
9 (32.1%)
|
0.223
|
Crystalloid (ml) (Mean±SD)
|
2222±806 |
1821±495 |
0.087 |
Colloid Replacement (n, %)
Administered
Not administered
|
21 (58.3%)
15 (41.7%)
|
18 (64.3%)
10 (35.7%)
|
0.628
|
Hemorrhage (ml) (Mean±SD)
|
633.3±305.9 |
764.3±322.3 |
0.046 |
Erythrocyte Replacement (n, %)
Administered
Not administered
|
21 (58.3%)
15 (41.7%)
|
19 (67.9%)
9 (32.1%)
|
0.892
|